Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality “ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in December this year. Our company, in conjunction with […]
SAN DIEGO — ViaCyte, Inc., a privately-held regenerative medicine company with the first pluripotent stem cell-derived islet replacement therapy for the treatment of diabetes in clinical-stage development, today announced that the Company has entered into a non-exclusive licensing agreement with Takara Bio, Inc. Takara will utilize certain portions of ViaCyte’s cell differentiation technology to expand […]
Göteborg, Sweden, Takara Bio Europe AB, a wholly-owned subsidiary of Takara Bio Inc., announced today that it is launching the Cellartis iPS Cell to Hepatocyte Differentiation System and related ancillary products. This system provides a complete solution for directed differentiation of disease-specific or patient-specific human inducible pluripotent stem (hiPS) cells to hepatocytes by combining a […]
Brussels, Belgium – Ovizio Imaging Systems, an innovative Belgian company developing cell counting solutions based on quantitative microscopy for life sciences applications, today announces it has secured a funding round of €8m ($9.1m) co-led by New Science Ventures, a US-based venture capital firm, and a private investor. This funding round also includes Qbic, Nausicaa Ventures, […]
MIAMI — Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer. The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering […]
Stockholm – IFS, the global enterprise applications company, announces that Sartorius AG — a leading pharmaceutical and laboratory equipment supplier—will implement IFS Field Service Management™ at 50 sites worldwide. The software is a core part of the Enterprise Service Management offering. The agreement includes licenses and services worth more than 1.5 million euros. Following a […]
MADISON, WIS. – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an agreement with Roche to supply CDI’s induced pluripotent stem cell (iPSC)-derived iCell products to contribute to the identification of novel drug candidates at the early stages of drug discovery. Key Points Under the terms of the supply and license agreement, Roche […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has secured final approval from the European Commission (EC) on the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany. The EC provided conditional approval of the acquisition on June 15, 2015, subject to approval of the divestment of certain Sigma-Aldrich assets. On October 20, […]
Darmstadt, Germany – Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich. The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the divestment of certain Sigma-Aldrich assets. On Oct. 20, 2015, […]
San Diego, CA — ACEA Biosciences, Inc., a privately held drug discovery and scientific instrumentation company, announced today that it has closed a new round of venture funding in the amount of $30 million. The funding was provided by Lilly Asia Ventures and Qiming Venture Partners. Over the past few years, ACEA has developed a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
